These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 31906573)

  • 1. Gastroesophageal Reflux Disease and Probiotics: A Systematic Review.
    Cheng J; Ouwehand AC
    Nutrients; 2020 Jan; 12(1):. PubMed ID: 31906573
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Randomised clinical trial: the clinical efficacy and safety of an alginate-antacid (Gaviscon Double Action) versus placebo, for decreasing upper gastrointestinal symptoms in symptomatic gastroesophageal reflux disease (GERD) in China.
    Sun J; Yang C; Zhao H; Zheng P; Wilkinson J; Ng B; Yuan Y
    Aliment Pharmacol Ther; 2015 Oct; 42(7):845-54. PubMed ID: 26228097
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy and safety of Amla (Phyllanthus emblica L.) in non-erosive reflux disease: a double-blind, randomized, placebo-controlled clinical trial.
    Karkon Varnosfaderani S; Hashem-Dabaghian F; Amin G; Bozorgi M; Heydarirad G; Nazem E; Nasiri Toosi M; Mosavat SH
    J Integr Med; 2018 Mar; 16(2):126-131. PubMed ID: 29526236
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Belching: dyspepsia or gastroesophageal reflux disease?
    Lin M; Triadafilopoulos G
    Am J Gastroenterol; 2003 Oct; 98(10):2139-45. PubMed ID: 14572558
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of coexisting upper gastrointestinal symptoms on daily life and quality of life in patients with gastroesophageal reflux disease symptoms.
    Isshi K; Furuhashi H; Koizumi A; Nakada K
    Esophagus; 2021 Jul; 18(3):684-692. PubMed ID: 33389239
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Frequency and clinical implications of supraesophageal and dyspeptic symptoms in gastroesophageal reflux disease.
    Mearin F; Ponce J; Ponce M; Balboa A; Gónzalez MA; Zapardiel J
    Eur J Gastroenterol Hepatol; 2012 Jun; 24(6):665-74. PubMed ID: 22330237
    [TBL] [Abstract][Full Text] [Related]  

  • 7. What is the efficacy of dietary, nutraceutical, and probiotic interventions for the management of gastroesophageal reflux disease symptoms? A systematic literature review and meta-analysis.
    Martin Z; Spry G; Hoult J; Maimone IR; Tang X; Crichton M; Marshall S
    Clin Nutr ESPEN; 2022 Dec; 52():340-352. PubMed ID: 36513474
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of gastroesophageal reflux disease on daily life: the Systematic Investigation of Gastrointestinal Diseases in China (SILC) epidemiological study.
    Wang R; Zou D; Ma X; Zhao Y; Yan X; Yan H; Fang J; Yin P; Kang X; Li Q; Dent J; Sung JJ; Halling K; Johansson S; Liu W; He J
    Health Qual Life Outcomes; 2010 Nov; 8():128. PubMed ID: 21062502
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence of gastroesophageal reflux disease in Moscow.
    Bor S; Lazebnik LB; Kitapcioglu G; Manannikof I; Vasiliev Y
    Dis Esophagus; 2016; 29(2):159-65. PubMed ID: 25604401
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Canadian Consensus Conference on the management of gastroesophageal reflux disease in adults - update 2004.
    Armstrong D; Marshall JK; Chiba N; Enns R; Fallone CA; Fass R; Hollingworth R; Hunt RH; Kahrilas PJ; Mayrand S; Moayyedi P; Paterson WG; Sadowski D; van Zanten SJ;
    Can J Gastroenterol; 2005 Jan; 19(1):15-35. PubMed ID: 15685294
    [TBL] [Abstract][Full Text] [Related]  

  • 11. AGA Clinical Practice Update on the Personalized Approach to the Evaluation and Management of GERD: Expert Review.
    Yadlapati R; Gyawali CP; Pandolfino JE;
    Clin Gastroenterol Hepatol; 2022 May; 20(5):984-994.e1. PubMed ID: 35123084
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sleep disturbance due to heartburn and regurgitation is common in patients with functional dyspepsia.
    Vakil N; Wernersson B; Wissmar J; Dent J
    United European Gastroenterol J; 2016 Apr; 4(2):191-8. PubMed ID: 27087946
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Health-related quality of life and severity of symptoms in patients with Barrett's esophagus and gastroesophageal reflux disease patients without Barrett's esophagus.
    Eloubeidi MA; Provenzale D
    Am J Gastroenterol; 2000 Aug; 95(8):1881-7. PubMed ID: 10950030
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epidemiology of gastroesophageal reflux disease in Iran: a systematic review and meta-analysis.
    Karimian M; Nourmohammadi H; Salamati M; Hafezi Ahmadi MR; Kazemi F; Azami M
    BMC Gastroenterol; 2020 Sep; 20(1):297. PubMed ID: 32928126
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-Heartburn Effects of Sugar Cane Flour: A Double-Blind, Randomized, Placebo-Controlled Study.
    Beckett JM; Singh NK; Phillips J; Kalpurath K; Taylor K; Stanley RA; Eri RD
    Nutrients; 2020 Jun; 12(6):. PubMed ID: 32570710
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Multicentre study "Epidemiology of gastroesophageal reflux disease in Russia"(MEGRE): first results].
    Lazebnik LB; Masharova AA; Bordin DS; Vasil'ev IuV; Tkachenko EI; Abdulkhakov RA; Butov MA; Eremina EIu; Zinchuk LI; Tsukanov VV
    Eksp Klin Gastroenterol; 2009; (6):4-12. PubMed ID: 20205320
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Onset of relief of symptoms of gastroesophageal reflux disease: post hoc analysis of two previously published studies comparing pantoprazole 20 mg once daily with nizatidine or ranitidine 150 mg twice daily.
    Haag S; Holtmann G
    Clin Ther; 2010 Apr; 32(4):678-90. PubMed ID: 20435237
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Randomised clinical trial: relief of upper gastrointestinal symptoms by an acid pocket-targeting alginate-antacid (Gaviscon Double Action) - a double-blind, placebo-controlled, pilot study in gastro-oesophageal reflux disease.
    Thomas E; Wade A; Crawford G; Jenner B; Levinson N; Wilkinson J
    Aliment Pharmacol Ther; 2014 Mar; 39(6):595-602. PubMed ID: 24471505
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gastroesophageal reflux disease in a low-income region in Turkey.
    Bor S; Mandiracioglu A; Kitapcioglu G; Caymaz-Bor C; Gilbert RJ
    Am J Gastroenterol; 2005 Apr; 100(4):759-65. PubMed ID: 15784016
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Randomized clinical trial: a double-blind, placebo-controlled study to assess the clinical efficacy and safety of alginate-antacid (Gaviscon Double Action) chewable tablets in patients with gastro-oesophageal reflux disease.
    Wilkinson J; Wade A; Thomas SJ; Jenner B; Hodgkinson V; Coyle C
    Eur J Gastroenterol Hepatol; 2019 Jan; 31(1):86-93. PubMed ID: 30272584
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.